Aaron Wealth Advisors’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
Other funds holding EPZM
RM
NM
RSCM
PAI
PIM
RCMNY
WP
Aaron Wealth Advisors's EPZM Position: Q2 2022 in Review
Aaron Wealth Advisors sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 276 shares — an estimated $240K sold.
Aaron Wealth Advisors first reported a position in EPZM in Q1 2022 and held it in 1 quarter. The position peaked at $240K in Q1 2022. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.
- Aaron Wealth Advisors reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
- Aaron Wealth Advisors sold 276 Epizyme, Inc shares in Q2 2022, an estimated $240K.
- Aaron Wealth Advisors first reported a position in Epizyme, Inc in Q1 2022 and held it in 1 quarter.
- Aaron Wealth Advisors's Epizyme, Inc position peaked at $240K in Q1 2022.
- 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.
Based on Aaron Wealth Advisors's 13F filing for Q2 2022, filed 22 Jul 2022.